News & Updates
Filter by Specialty:
Semaglutide trims down weight in patients with severe obesity
12 Jan 2024
byStephen Padilla
Use of semaglutide 2.4 mg results in substantial weight reduction in patients with severe obesity who had previously undergone bariatric surgery (BS) but failed to achieve satisfactory weight loss, reports a recent study.
Semaglutide trims down weight in patients with severe obesity
12 Jan 2024New models predict skeletal muscle mass reduction with calorie restriction
11 Jan 2024
A recent study has shown that healthy men and women with overweight or obesity who undergo voluntary calorie restriction (CR), without a structure exercise program, attain decreases in skeletal muscle (SM) mass of approximately 2 to 2.5 kg and 1 to 1.5 kg per 10-kg weight loss, respectively.
New models predict skeletal muscle mass reduction with calorie restriction
11 Jan 2024NIH study: Semaglutide associated with lower risk of suicidal ideation
11 Jan 2024
byKanas Chan
Semaglutide is associated with a 49─73 percent lower risk of suicidal ideation vs other agents for treatment of obesity and type 2 diabetes mellitus (T2DM), a National Institutes of Health (NIH)─funded study has shown.